MiNK Therapeutics INKT
NASDAQ INKT
$12.58 -0.15 (-1.18%)
As of: Oct 2, 2026 · 9:37 AM EDT

MiNK Therapeutics (INKT) Accumulated Depreciation (2020 - 2025)

Updated

MiNK Therapeutics (INKT) recorded Accumulated Depreciation of $612,245 in Q4 2025, up 16.6% from $525,000 a year earlier.

Analysis

MiNK Therapeutics (INKT) Accumulated Depreciation (2020 - 2025) Analysis & Trends

Starting with Q4 2020, MiNK Therapeutics' Accumulated Depreciation history includes 6 quarters.

  • Annual Accumulated Depreciation has increased for five straight years, with a five-year compound annual growth rate of 44.2% (FY2020 to FY2025).
  • Across earlier years, Accumulated Depreciation came in at $525,000 in FY2024 (+5.8%), $496,000 in FY2023 (+74.6%), $284,000 in FY2022 (+68.0%) and $169,000 in FY2021 (+72.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 MiNK Therapeutics 63.96 Mn 63.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 612,245.00
Dec 31, 2024 525,000.00
Dec 31, 2023 496,000.00
Dec 31, 2022 284,000.00
Dec 31, 2021 169,000.00
Dec 31, 2020 98,160.00
API Access

MiNK Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=INKT&period=max&api_key=YOUR_API_KEY